Prescribing of bicalutamide should be restricted to patients at high risk of disease progression News item 19 January 2013 Pages: 2 - 2
FDA in favour of boxed warning for gadolinium-based contrast agents News item 19 January 2013 Pages: 2 - 2
The US FDA has received 1637 reports of adverse reactions associated with recombinant quadrivalent human papillomavirus vaccine [Gardasil] Media release 19 January 2013 Pages: 2 - 2
Patients with the 5-HTTLPR s/s or s/l genotype may be at increased risk for adverse events (AEs) News item 19 January 2013 Pages: 3 - 3
US FDA black box warning alters antidepressant prescribing Clinical study 19 January 2013 Pages: 3 - 3
Elderly patients should have their electrolytes measured 3-5 days following initiation of venlafaxine for depression Clinical study 19 January 2013 Pages: 3 - 3
Oral contraceptives (OCs) pose no increased risk of serious adverse events (SAEs) or fatalities Media release 19 January 2013 Pages: 3 - 3
